What’s Fueling the Bull Run in Biotech Stocks?

July 19 (Bloomberg) -- Bloomberg's Olivia Sterns examines the bull run in the biotech sector as the FDA approvals reach a 15-year high. She speaks on Bloomberg Television's "In The Loop."
H-Shares Valuations Still Attractive: UBS Wealth's Tay
31:21 - Kelvin Tay, Singapore-based chief investment officer for Southern Asia Pacific at UBS Wealth Management, talks about China's stocks and central bank policy. Tay also discusses Greece's debt problems and their implications for European and Asian markets. He speaks with Yvonne Man on Bloomberg Television's "First Up." (Source: Bloomberg)
  • China A-Shares in Bear Market as Index Falls 22%
  • AOL to Take Over Microsoft's Display Ad Business
  • Greece Needs Monti-Like Bureaucratic Government: Jakobsen